JMi ONConsulting

Providing additional keys and solutions to support your pharmaceutical drug research and early clinical development programs.

ABOUT 

Michel JANICOT, Ph.D.

Founder & Managing Director, JMi ONConsulting

Ph.D. Biochemistry

Molecular and Cellular Biology

April 1988:  Magna cum laude from Université Paris VII (France)

Postdoctoral Fellow

Biological Chemistry

1988 – 1992:  The Johns Hopkins University (Baltimore, MD, USA)

30+ years hands-on experience in pharmaceutical drug research and early clinical development

350+ invited lectures, patents, book chapters, peer-reviewed publications, and abstracts

Rhône-Poulenc Rorer (Sanofi)

1992 – 1998:  Vitry s/Seine (France)

Janssen Pharmaceutica (Johnson & Johnson)

1999 – 2012:  Beerse (Belgium)

JMi ONConsulting

from 2012:  Brussels (Belgium)

aPODD Foundation

from 2012:  London (UK)

CURRENT ROLES

Founder and Managing Director

To provide additional keys and solutions to support your pharmaceutical drug research and early clinical development programs.

  Strategic preclinical project portfolio management
  Drug Discovery
  Lead Optimization
  Medicinal Chemistry & Manufacturing (via network)
  
Preclinical Development
  IND/CTA filing Process
  Translational Medicine
  Early Clinical Development
  Scientific Licensing
  Fund raising campaigns (road show)

Co-Founder and Director/Trustee

To accelerate the development and approval of new drugs to treat children with cancer.  Specific drugs are not being developed and children gain only  very limited benefit from the newer anti-cancer therapies that are approved for  adults.” 

aPODD Foundation is a registered charity in England and Wales and is a company limited by guarantee in England and Wales. 

International scientific and technical expertise, and support.

20+ New Molecular Entities brought into first-in-human studies and further early clinical development.

CURRENT (PART-TIME) ASSIGNMENTS

Head of R&D and Chief Development Officer

InteRNA Technologies
Utrecht, the Netherlands

Vice President - Research

Flamingo Therapeutics
Leuven, Belgium

Chief Development Officer

Onena Medicines
San Sebastian, Spain

Co-Founder & Board of Directors Member

aPODD Foundation
London, UK

Board of Directors Member

Experimentica
Kuopio, Finland

Preclinical/Phase 1 Development Advisor

Acctena AB
Åkers Styckebruk, Sweden

Scope & Capacities

In-Licensing Opportunities

  • Scouting and initial screening of potential opportunities to fit and complement your internal project pipeline
  • Initial scientific evaluation and coordination of due diligence

Out-Licensing Opportunities

  • Scouting and initial screening of potential partners
  • Preparation of scientific information package for due diligence
  • Preparation (coaching) of scientific presentations to potential partners
  • Coordination and management of due diligence process

Internal Pharmaceutical Drug R&D Projects

  • ‘C’ level management position
  • Pharmaceutical Res. & early Dev. process, procedures and (regulatory/scientific) requirements
  • Internal project evaluation (value proposition), management and scientific development
  • Strategic and scientific project portfolio management
  • Introduction to Contract Research Organizations (CROs) and outsourced activities : challenges & opportunities
  • Coaching/preparation to (internal/external) scientific and strategic presentations
  • Fund raising process

CONTACT

Privacy Policy

Michel Janicot

Michel Janicot

Founder & Managing Director